Here are four notes:
1. The analyst believes that the company’s Fuse endoscopy system, along with its single use products, will drive sustainable growth of 20 percent to 30 percent for the next few years.
2. Fuse endoscopy provides up to a 330 degree view of the colon, and a study found that the system allows doctors to detect 69 percent more adenomas than existing technology.
3. The analyst believes that Fuse could contribute nearly 80 percent of EndoChoice’s revenue growth through 2018.
4. “EndoChoice is the only company to address the continuum of care in the $6 billion worldwide gastrointestinal market through its single-use products, Fuse endoscopy system and in-house pathology services,” notes the William Blair report.
More articles on GI/endoscopy:
David Hemink named president of Medivators
Digestive Health Specialists of Tyler affiliates with Trinity Mother Frances Hospital & Clinics
GI physician leader to know: Dr. Robert Sandler of UNC School of Medicine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.